Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cerament G in partial calcanectomy for heel bone infection

Official title: Randomised Controlled Trial Comparing Partial Calcanectomy Plus Local Application Antibiotic Impregnated Bone Graft Substitute for Calcaneal Osteomyelitis vs Partial Calcanectomy Alone (The ACHILLS Trial)

Run by Royal College of Surgeons, Ireland · NCT07057817 · Data updated 2026-11-12

This trial tests whether adding Cerament G to partial calcanectomy helps heal wounds and lower reinfection in adults with calcaneal osteomyelitis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorRoyal College of Surgeons, Ireland
Academic / other
Locations1 site (Galway)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJuly 2029
Study endsDecember 2029
Registry record updatedJuly 22, 2026
Trial IDNCT07057817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older undergoing partial calcanectomy for calcaneal osteomyelitis, with diabetes (Type 1 or 2).

Probably not a fit

Patients without calcaneal osteomyelitis, those not undergoing partial calcanectomy, or those with contraindications to Cerament G or surgery may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized feasibility study compares partial calcanectomy with Cerament G versus partial calcanectomy with standard antibiotic therapy alone for calcaneal osteomyelitis. Thirty adults will be followed for one year to measure wound healing rates, time to heal, re-infection, hospital stay, antibiotic use, costs, and quality of life. Participants are randomly assigned to receive Cerament G during surgery or not and will be stratified by pulse status and eGFR. The study aims to determine if Cerament G is feasible and potentially beneficial in this setting before a larger trial. Outcomes will inform whether this approach merits broader adoption.

Why it matters

Potential benefit: If Cerament G proves beneficial, patients may experience faster wound healing, fewer infections, shorter hospital stays, and improved quality of life.

How similar studies have gone: Previous work in similar orthopedic infections suggests potential benefits of antibiotic-impregnated grafts, but this specific partial calcanectomy approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 and over
* Undergoing partial calcanectomy
* Patients with Type1 or Type 2 Diabetes
* Patients will be stratified by Pulse status and eGFR

Exclusion Criteria:

* Patients unfit for surgery
* Patients unable to provide informed consent
* Patients with overwhelming sepsis that require major amputation
* Patients with hypersensitivity to aminoglycosides
* Pre-existing calcium metabolism disorder
* Severe renal impairment
* Patients in whom major limb amputation is deemed inevitable by the treating physician

Where it's running

  • University Hospital Galway
    Galway, Ireland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.